Meningitis management
35,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Broschiertes Buch

Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. A ray of hope for the victims of meningitis a new vaccine has been approved for treating meningitis B. The new vaccine, which medical researchers have named as 4CMenB vaccine, has been developed and manufactured by the pharmaceutical company Novartis. It is essential to note that the 4CMenB vaccine is the first meningitis B vaccine which has been approved for use in the United Kingdom. Besides, the vaccine has received a positive verdict from the European Medicines…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. A ray of hope for the victims of meningitis a new vaccine has been approved for treating meningitis B. The new vaccine, which medical researchers have named as 4CMenB vaccine, has been developed and manufactured by the pharmaceutical company Novartis. It is essential to note that the 4CMenB vaccine is the first meningitis B vaccine which has been approved for use in the United Kingdom. Besides, the vaccine has received a positive verdict from the European Medicines Agency which indicates that the 4CMenB vaccine is safe and effective. Nonetheless, Novartis has said the immunization has had side effects such as fever and redness at the injection site. Also known as Bexsero, the vaccine 4CMenB is medically recommended for use in children aged two months and older. Did you know that there is an average of 1 870 people who suffers from meningitis B in Great Britain. Official medical reports have also revealed that among the victims, 85% are children. Meningitis B also referred to as the meningococcal disease is caused by Neisseria meningitidis group B...